Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.

What Was Tested

This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and GHRH (Growth Hormone-Releasing Hormone).

GH-releasing hormone (GHRH) testing was performed before and after 6 and 12 months of hGH therapy.

Who Took Part

The abstract describes 25 boys taking part.

PubMed indexes the participants as children, both men and women.

How the Study Was Run

The design is described as randomized.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

GH-releasing hormone (GHRH) testing was performed before and after 6 and 12 months of hGH therapy.

The subject headings attached to it are Antibody Formation, Body Height, Feedback, Growth Hormone, Growth Hormone-Releasing Hormone, Injections and Insulin-Like Growth Factor I.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and GHRH (Growth Hormone-Releasing Hormone) in 25 boys.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 1991 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page and the GHRH (Growth Hormone-Releasing Hormone) compound page, all human trials.